These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31023256)

  • 61. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
    Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
    Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis.
    Baykara O; Dalay N; Bakir B; Bulut P; Kaynak K; Buyru N
    Int J Med Sci; 2017; 14(7):675-679. PubMed ID: 28824300
    [No Abstract]   [Full Text] [Related]  

  • 65. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.
    Neumeister VM; Sullivan CA; Lindner R; Lezon-Geyda K; Li J; Zavada J; Martel M; Glazer PM; Tuck DP; Rimm DL; Harris L
    Breast Cancer Res Treat; 2012 Nov; 136(1):67-75. PubMed ID: 22976806
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.
    Wang Z; Zhang J; Zhang Y; Deng Q; Liang H
    Int J Mol Med; 2018 Dec; 42(6):3542-3550. PubMed ID: 30221688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors.
    Choi EK; Lim JA; Kim JK; Jang MS; Kim SE; Baek HJ; Park EJ; Kim TH; Deng CX; Wang RH; Kim SS
    Exp Mol Med; 2018 Oct; 50(10):1-16. PubMed ID: 30327455
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
    Arnes JB; Brunet JS; Stefansson I; Bégin LR; Wong N; Chappuis PO; Akslen LA; Foulkes WD
    Clin Cancer Res; 2005 Jun; 11(11):4003-11. PubMed ID: 15930334
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
    Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
    Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.
    Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J
    Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients.
    Hautala LC; Greco D; Koistinen R; Heikkinen T; Heikkilä P; Aittomäki K; Blomqvist C; Koistinen H; Nevanlinna H
    Breast Cancer Res Treat; 2011 Jul; 128(1):85-95. PubMed ID: 20676758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Computational analysis of Cyclin D1 gene SNPs and association with breast cancer.
    Aftab A; Khan R; Shah W; Azhar M; Unar A; Jafar Hussain HM; Waqas A
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33438725
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A role for BRCA1 in sporadic breast cancer.
    Fraser JA; Reeves JR; Stanton PD; Black DM; Going JJ; Cooke TG; Bartlett JM
    Br J Cancer; 2003 Apr; 88(8):1263-70. PubMed ID: 12698194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival.
    Li W; Amei A; Bui F; Norouzifar S; Lu L; Wang Z
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interplay of tRNA-Derived Fragments and T Cell Activation in Breast Cancer Patient Survival.
    Shan N; Li N; Dai Q; Hou L; Yan X; Amei A; Lu L; Wang Z
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32785169
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
    Mateo F; He Z; Mei L; de Garibay GR; Herranz C; García N; Lorentzian A; Baiges A; Blommaert E; Gómez A; Mirallas O; Garrido-Utrilla A; Palomero L; Espín R; Extremera AI; Soler-Monsó MT; Petit A; Li R; Brunet J; Chen K; Tan S; Eaves CJ; McCloskey C; Hakem R; Khokha R; Lange PF; Lázaro C; Maxwell CA; Pujana MA
    Nat Commun; 2022 Apr; 13(1):1895. PubMed ID: 35393420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BRCA1: linking HOX to breast cancer suppression.
    Jin K; Sukumar S
    Breast Cancer Res; 2010; 12(4):306. PubMed ID: 20727230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.